{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:36:27Z","timestamp":1740166587385,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Center for Child Health and Development grant","award":["26-26"],"award-info":[{"award-number":["26-26"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["26300101"],"award-info":[{"award-number":["26300101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13643-016-0236-2","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:46:02Z","timestamp":1460623562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis"],"prefix":"10.1186","volume":"5","author":[{"given":"Osamu","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"issue":"9433","key":"236_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004;364(9433):533\u201344.","journal-title":"Lancet"},{"issue":"3","key":"236_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki T, Kosaki F, Okawa S, et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271\u20136.","journal-title":"Pediatrics"},{"key":"236_CR3","unstructured":"Japanese Kawasaki Disease Research Center. The 23rd nationwide survey of Kawasaki disease in Japan. Available at: http:\/\/www.jichi.ac.jp\/dph\/kawasakibyou\/20150924\/mcls23report1013.pdf . Accessed 31 Mar 2016"},{"key":"236_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/archdischild-2012-302841","volume":"99","author":"D Eleftheriou","year":"2014","unstructured":"Eleftheriou D, Levin M, Shingadia D, et al. Management of Kawasaki disease. Arch Dis Child. 2014;99:74\u201383.","journal-title":"Arch Dis Child"},{"key":"236_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/anr.1780320914","volume":"32","author":"EW Jeffes 3rd","year":"1989","unstructured":"Jeffes 3rd EW, Ininns EK, Schmitz KL, et al. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum. 1989;32:1148\u201352.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"236_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ped.12317","volume":"56","author":"Research Committee of the Japanese Society of Pediatric C","year":"2014","unstructured":"Research Committee of the Japanese Society of Pediatric C, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki D. Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int. 2014;56(2):135\u201358.","journal-title":"Pediatr Int"},{"issue":"6","key":"236_CR7","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708\u201333.","journal-title":"Pediatrics"},{"issue":"12","key":"236_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","volume":"17","author":"JC Burns","year":"1998","unstructured":"Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J. 1998;17(12):1144\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"236_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2188\/jea.JE20090180","volume":"20","author":"Y Nakamura","year":"2010","unstructured":"Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007\u20132008 nationwide survey. J Epidemiol. 2010;20(4):302\u20137.","journal-title":"J Epidemiol"},{"key":"236_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cyto.2014.07.003","volume":"70","author":"T Fujimaru","year":"2014","unstructured":"Fujimaru T, Ito S, Masuda H, et al. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Cytokine. 2014;70:156\u201360.","journal-title":"Cytokine"},{"key":"236_CR11","first-page":"1","volume":"24","author":"T Oharaseki","year":"2013","unstructured":"Oharaseki T, Yokouchi Y, Yamada H, et al. The role of TNF-(alpha) in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide. Mod Rheumatol. 2013;24:1\u20139.","journal-title":"Mod Rheumatol"},{"key":"236_CR12","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:1731\u20138.","journal-title":"Lancet"},{"key":"236_CR13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jpeds.2010.06.014","volume":"157","author":"NF Choueiter","year":"2010","unstructured":"Choueiter NF, Olson AK, Shen DD, et al. Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease. J Pediatr. 2010;157:960\u201366.e1.","journal-title":"J Pediatr"},{"key":"236_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jpeds.2008.06.011","volume":"153","author":"JC Burns","year":"2008","unstructured":"Burns JC, Best BM, Mejias A, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008;153:6.","journal-title":"J Pediatr"},{"key":"236_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1546-0096-12-26","volume":"12","author":"A Shafferman","year":"2014","unstructured":"Shafferman A, Birmingham JD, Cron RQ. High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report. Pediatr Rheumatol Online J. 2014;12:26.","journal-title":"Pediatr Rheumatol Online J"},{"key":"236_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jpeds.2012.01.018","volume":"160","author":"E Sauvaget","year":"2012","unstructured":"Sauvaget E, Bonello B, David M, et al. Resistant Kawasaki disease treated with anti-CD20. J Pediatr. 2012;160:875\u20136.","journal-title":"J Pediatr"},{"key":"236_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1136\/annrheumdis-2012-201658","volume":"71","author":"S Cohen","year":"2012","unstructured":"Cohen S, Tacke CE, Straver B, et al. A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Ann Rheum Dis. 2012;71:2059\u201361.","journal-title":"Ann Rheum Dis"},{"key":"236_CR18","first-page":"1166","volume":"29","author":"T Imagawa","year":"2009","unstructured":"Imagawa T, Miyamae T, Kishi T, et al. Effectiveness of tocilizumab for intravenous immunoglobulin-resistant Kawasaki disease. Prog Med. 2009;29:1166.","journal-title":"Prog Med"},{"key":"236_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ped.12349","volume":"56","author":"T Saji","year":"2014","unstructured":"Saji T. Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int. 2014;56:135\u201358.","journal-title":"Pediatr Int"},{"key":"236_CR20","volume-title":"Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease","author":"Research Committee on Kawasaki Disease","year":"1984","unstructured":"Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare; 1984."},{"key":"236_CR21","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.","journal-title":"BMJ"},{"key":"236_CR22","unstructured":"Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration; 2011."},{"issue":"4","key":"236_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","volume":"66","author":"SY Kim","year":"2013","unstructured":"Kim SY, Park JE, Lee YJ, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408\u201314.","journal-title":"J Clin Epidemiol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0236-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-016-0236-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0236-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0236-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T20:07:38Z","timestamp":1655496458000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-016-0236-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1186\/s13643-016-0236-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"assertion":[{"value":"19 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}